These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 30281132)

  • 1. Cardiovascular disease in dialysis patients.
    Cozzolino M; Mangano M; Stucchi A; Ciceri P; Conte F; Galassi A
    Nephrol Dial Transplant; 2018 Oct; 33(suppl_3):iii28-iii34. PubMed ID: 30281132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaemia and early phase cardiovascular events on haemodialysis.
    Hayashi T; Joki N; Tanaka Y; Hase H
    Nephrology (Carlton); 2015 Dec; 20 Suppl 4():1-6. PubMed ID: 26456311
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the inflammatory and oxidative stress markers during a single hemodialysis session in patients with chronic kidney disease.
    Sangeetha Lakshmi B; Harini Devi N; Suchitra MM; Srinivasa Rao PVLN; Siva Kumar V
    Ren Fail; 2018 Nov; 40(1):534-540. PubMed ID: 30277113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. oxLDL - the molecule linking hypercoagulability with the presence of cardiovascular disease in hemodialyzed uraemic patients.
    Pawlak K; Mysliwiec M; Pawlak D
    Thromb Res; 2014 Sep; 134(3):711-6. PubMed ID: 25065558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodialysis-induced cardiovascular disease.
    Ahmadmehrabi S; Tang WHW
    Semin Dial; 2018 May; 31(3):258-267. PubMed ID: 29624739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular disease in patients with chronic kidney disease. A clinical review.
    Kaisar M; Isbel N; Johnson DW
    Minerva Urol Nefrol; 2007 Sep; 59(3):281-97. PubMed ID: 17912225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients.
    Noordzij M; Korevaar JC; Bos WJ; Boeschoten EW; Dekker FW; Bossuyt PM; Krediet RT
    Nephrol Dial Transplant; 2006 Sep; 21(9):2513-20. PubMed ID: 16799173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.
    McCullough PA; Chan CT; Weinhandl ED; Burkart JM; Bakris GL
    Am J Kidney Dis; 2016 Nov; 68(5S1):S5-S14. PubMed ID: 27772643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal dialysis for the end-stage renal disease patient with cardiovascular disease.
    Dumler F; McCullough PA
    Adv Chronic Kidney Dis; 2004 Jul; 11(3):261-73. PubMed ID: 15241741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular complications in end-stage renal disease and hemodialysis patients.
    Kes P; Drusko D; Rupcić V
    Acta Med Croatica; 1996; 50(4-5):199-208. PubMed ID: 9046118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
    Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
    Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic inflammation and cardiovascular risk in hemodialysis].
    Pertosa G; Simone S; Soccio M; Marrone D; Grandaliano G
    G Ital Nefrol; 2003; 20(6):631-40. PubMed ID: 14732917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular disease in end-stage renal disease: the challenge of assessing and managing cardiac disease in dialysis patients.
    Miller LM; Sood MM; Sood AR; Reslerova M; Komenda P; Rigatto C; Bueti J
    Int Urol Nephrol; 2010 Dec; 42(4):1007-14. PubMed ID: 20960231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic inflammation in end-stage renal disease and dialysis.
    Cobo G; Lindholm B; Stenvinkel P
    Nephrol Dial Transplant; 2018 Oct; 33(suppl_3):iii35-iii40. PubMed ID: 30281126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of vascular disease in renal failure.
    Ikizler TA
    Blood Purif; 2002; 20(1):6-10. PubMed ID: 11803153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of haemodiafiltration with online regeneration of ultrafiltrate on oxidative stress in dialysis patients.
    Calò LA; Naso A; Carraro G; Wratten ML; Pagnin E; Bertipaglia L; Rebeschini M; Davis PA; Piccoli A; Cascone C
    Nephrol Dial Transplant; 2007 May; 22(5):1413-9. PubMed ID: 17237480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-γ-coactivator 1α (PGC-1α) gene expression in chronic kidney disease patients on hemodialysis: relation to hemodialysis-related cardiovascular morbidity and mortality.
    Elsayed ET; Nassra RA; Naga YS
    Int Urol Nephrol; 2017 Oct; 49(10):1835-1844. PubMed ID: 28550474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung congestion as a risk factor in end-stage renal disease.
    Zoccali C; Tripepi R; Torino C; Bellantoni M; Tripepi G; Mallamaci F
    Blood Purif; 2013; 36(3-4):184-91. PubMed ID: 24496189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
    Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
    Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular outcome in asymptomatic hemodialysis patients submitted to aggressive medical therapy: results of a four-year follow-up.
    Summaria F; Manca Di Villahermosa S; Tedesco M; Lonzi M; Colarieti G; Chamoun MG; Taccone Gallucci M
    Minerva Cardioangiol; 2011 Apr; 59(2):121-6. PubMed ID: 21242949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.